Immucor products
Transfusion - Automation
Echo Lumena - Fully Automated Type and Screen System
Echo Lumena provides the fastest, fully automated type and screen on the market today while also offering the smallest footprint. Run tests in 3 easy steps. Pre-coated antigens; fewer reagents to manage and less pipetting.
Transfusion - Typing, Screening & Identification
ABO - Reverse Grouping - Referencells
Immucor is proud to offer the broadest product line of traditional Reagent Red Blood Cells on the global market.
Transplant - HLA Typing Portfolio
Mia Fora - Model NGS MFlex HLA - Genotyping Typing Kits
The MIA FORA HLA typing solution offers high-resolution HLA genotyping of Class I and Class II loci. Report high-quality Next Generation Sequencing (NGS) HLA Typing results, with an optimized workflow, in less time than ever before using the MIA FORA NGS MFlex HLA Typing Kit.
Transplant - Antibody Portfolio
Lifecodes - Model LifeScreen Deluxe - HLA Antibody Detection System
Antibody screening with enhanced sensitivity for better results. The LIFECODES HLA Antibody Detection System utilizes Luminex® xMAP® technology to achieve flow cytometric sensitivity. LIFECODES LifeScreen Deluxe contains seven different Class I beads and five Class II beads. The sensitivity has been enhanced through the use of CREG-enriched beads.
Transplant - Analyzers
LUMINEX and FLEXMAP 3D - Model 200 - XMAP - Flow-Based Reader Analyzers
Optimize your lab’s performance with automation. Perform up to 100 different tests in a single reaction volume with the Luminex 200, a flow-based reader. Additionally, the Luminex 200 is able to offer higher sample throughput with a 96-well plate read time of only 45 minutes. The FLEXMAP 3D, a flow-based reader, is the most advanced and versatile multiplexing platform from Luminex. It is simple to use and maintain with fast read time and automated startup, shutdown, and maintenance routines.
Coagulation
ADAMTS - Model ATS-13 - Activity Assay System
What is your testing algorithm for patients suspected of having thrombotic thrombocytopenic purpura (TTP)? ATS-13 Activity Assay provides protocols to quantitatively measure ADAMTS-13 protease activity and determine the presence of inhibitory antibodies to ADAMTS-13 in human plasma. ADAMTS-13 is the protease that cleaves von Willebrand Factor. Significant decreases or an absence of ADAMTS-13 activity can lead to the formation of ultra-large vWF fragments and trigger intravascular platelet aggregation and microthrombosis, causing the signs and symptoms of thrombotic thrombocytopenic purpura, TTP.
